HDAC9 and diabetic kidney disease: Amongst all of the epigenetic processes identified to date, histone deacetylation has revealed itself to be the most amenable to therapeutic manipulation and thus HDAC inhibitors have begun to be explored as treatments for diabetic kidney disease in experimental models.